Stephen Feider, Chief Financial Officer at Beta Bionics, Inc. (BBNX), sold 6,676 shares at $12.61 ($84K) on 2026-06-02, disclosed to the SEC on 2026-06-03.
Open-market sale of $84k BBNX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| BBNX | SELL | 2026-03-03 | $18K | — | Filing → |
| BBNX | SELL | 2026-01-05 | $591K | — | Filing → |
| BBNX | SELL | 2025-12-04 | $42K | — | Filing → |